Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk

Carcinogenesis

Volumn 32, Issue 11, 2011, Pages 1655-1659

  Jin, Guangfu ^a   Sun, Jielin ^a   Isaacs, Sarah D ^b   Wiley, Kathleen E ^b   Kim, Seong Tae ^a   Chu, Lisa W ^a   Zhang, Zheng ^a   Zhao, Hui ^a   Zheng, Siqun Lilly ^a   Isaacs, William B ^b   Xu, Jianfeng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG NON CODING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER RISK; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENOME; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; META-ANALYSIS AS TOPIC; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS; RNA, UNTRANSLATED;

EID: 80755187776     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr187     Document Type: Article

References (43)

1. Bertone,P. et al. (2004) Global identification of human transcribed sequences with genome tiling arrays. Science, 306, 2242-2246.
2. ENCODE Project Consortium et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
3. Cheng,J. et al. (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science, 308, 1149-1154.
4. Kapranov,P. et al. (2007) RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316, 1484-1488.
5. Ponting,C.P. et al. (2009) Evolution and functions of long noncoding RNAs. Cell, 136, 629-641.
6. Carthew,R.W. et al. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell, 136, 642-655.
7. Malone,C.D. et al. (2009) Small RNAs as guardians of the genome. Cell, 136, 656-668.
8. Baek,D. et al. (2008) The impact of microRNAs on protein output. Nature, 455, 64-71.
9. Selbach,M. et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature, 455, 58-63.
10. Ørom,U.A. et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell, 143, 46-58.
11. Nagano,T. et al. (2011) No-nonsense functions for long noncoding RNAs. Cell, 145, 178-181.
12. Hindorff,L.A. et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA, 106, 9362-9367.
13. Visel,A. et al. (2009) Genomic views of distant-acting enhancers. Nature, 461, 199-205.
14. Guttman,M. et al. (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458, 223-227.
15. Mattick,J.S. (2009) The genetic signatures of noncoding RNAs. PLoS Genet., 5, e1000459.
16. [1000] Genomes Project Consortium et al. (2010). A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
17. Hindorff,L.A. et al. A Catalog of Published Genome-Wide Association Studies. www.genome.gov/gwastudies (31 December 2010, date last accessed).
18. ENSEMBL BioMart [database on the Internet] uswest.ensembl.org/biomart/ martview (31 December 2010, date last accessed).
19. Amundadottir,L.T. et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat. Genet., 38, 652-658.
20. Gudmundsson,J. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
21. Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
22. Gudmundsson,J. et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet., 39, 977-983.
23. Duggan,D. et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Natl Cancer Inst., 99, 1836-1844.
24. Thomas,G. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
25. Gudmundsson,J. et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet., 40, 281-283.
26. Eeles,R.A. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
27. Yeager,M. et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat. Genet., 41, 1055-1057.
28. Gudmundsson,J. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
29. Eeles,R.A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
30. Sun,J. et al. (2008) Evidence for two independent prostate cancer riskassociated loci in the HNF1B gene at 17q12. Nat. Genet., 40, 1153-1155.
31. Hsu,F.C. et al. (2009) A novel prostate cancer susceptibility locus at 19q13. Cancer Res., 69, 2720-2723.
32. Sun,J. et al. (2009) Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res., 69, 10-15.
33. Kim,S.T. et al. (2010) Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation. Prostate, 70, 1729-1738.
34. Xu,J. et al. (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc. Natl Acad. Sci. USA, 107, 2136-2140.
35. Illumina iControlDB [website on the Internet]. Illumina, San Diego, CA, 2010 http://www.illumina.com/science/icontroldb.ilmn (11 September 2009, date last accesssed).
36. Price,A.L. et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
37. Purcell,S. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
38. Ponjavic,J. et al. (2007) Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res., 17, 556-565.
39. Chung,S. et al. (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci., 102, 245-252.
40. Zhong,H. et al. (2010) Integrating pathway analysis and genetics of gene expression for genome-wide association studies.Am. J. Hum. Genet., 86, 581-591.
41. Liu,J.Z. et al. (2010) A versatile gene-based test for genome-wide association studies. Am. J. Hum. Genet., 87, 139-145.
42. Hsieh,C.L. et al. (2001) A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am. J. Hum. Genet., 69, 148-158.
43. Wiklund,F. et al. (2003) Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate, 57, 290-297.